SCHEMBL27200082

SCHEMBL27200082

O=c1ccc2c([nH]1)-c1ncccc1OC2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.36
PDE3B Q13370 3/20 0.35
PDE3A Q14432 3/20 0.35
MAOB P27338 2/20 0.33
TDP2 O95551 1/20 0.33
NSD2 O96028 1/20 0.33
ABL1 P00519 1/20 0.33
PLCG1 P19174 1/20 0.33
CES1 P23141 1/20 0.33
PAX8 Q06710 1/20 0.33
RIN1 Q13671 1/20 0.33
MAPT P10636 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33
THRB P10828 1/20 0.33
BLM P54132 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GAA P10253 1/20 0.33
ROCK2 O75116 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18836577 0.78 TDP2 (0.36) KMT2APDE3BPDE3AMAOBTDP2
SCHEMBL27200075 0.76 KDM4E (0.44) MAPTSMN1; SMN2BLMTDP1GAA
SCHEMBL29606008 0.73 MAOB (0.43) KMT2AMAOBTDP2NSD2ABL1
SCHEMBL4507981 0.73 MAOB (0.43) KMT2AMAOBTDP2NSD2ABL1
Hydrochloric Acid SCHEMBL4501139 0.72 MAOB (0.42) KMT2AMAOBTDP2NSD2ABL1
SCHEMBL1728678 0.71 MAOA (0.47) KMT2AMAOBTDP2NSD2ABL1
SCHEMBL11635162 0.70 MAOB (0.47) KMT2AMAOBTDP2NSD2ABL1
SCHEMBL7000587 0.69 MAOB (0.54) KMT2AMAOBTDP2NSD2ABL1
SCHEMBL12461750 0.69 KMT2A (0.34) KMT2AROCK2
SCHEMBL2872670 0.67 TDP1 (0.39) KMT2ATDP2NSD2ABL1PLCG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025008288-A1 9-OXO-9,10-DIHYDRO-6H-PYRANO[3,2-B:4,5-B']DIPYRIDINE-8-CARBOXYLIC ACID DERIVATIVES CENTENARA LABS AG (CH) 2025-01-09 WO disclosed
WO-2025008288-A1 9-OXO-9,10-DIHYDRO-6H-PYRANO[3,2-B:4,5-B']DIPYRIDINE-8-CARBOXYLIC ACID DERIVATIVES CENTENARA LABS AG (CH) 2025-01-09 WO disclosed
WO-2025008288-A1 9-OXO-9,10-DIHYDRO-6H-PYRANO[3,2-B:4,5-B']DIPYRIDINE-8-CARBOXYLIC ACID DERIVATIVES CENTENARA LABS AG (CH) 2025-01-09 WO disclosed
US-11964986-B1 9-oxo-9,10-dihydro-6H-pyrano[3,2-b:4,5-b′]dipyridine-8-carboxylic acid derivatives REJUVERON TELOMERE THERAPEUTICS AG (CH) 2024-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11964986-B1 9-oxo-9,10-dihydro-6H-pyrano[3,2-b:4,5-b′]dipyridine-8-carboxylic acid derivatives DPP9, DPYD, QDPR KMT2A 3581/4885PDE3B 303/4885PDE3A 385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.